1d
JNJ stock reporting earnings, expecting $2 EPS and $22.44B revenue, approval for Spravato, mixed chart signals, $167.71 price ...
Troops have been previously deployed in the U.S. by presidents, including George H.W. Bush and John F. Kennedy.
Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the ...
On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback